Skip to main content
skinemerging evidence

Psoriasis Management

Published: Last updated:

Source: Clinical Research

Protocol for managing psoriasis plaques using red and near-infrared wavelengths. PBM can reduce the hyperproliferative and inflammatory components of psoriasis, potentially decreasing plaque thickness, scaling, and erythema.

Protocol Parameters

ConditionPsoriasis
Wavelengths630nm, 660nm, 830nm
Dosage3-6 J/cm²
Irradiance20-50 mW/cm²
Duration10-15 minutes per area
Frequency3-4x per week for 8-12 weeks
Body Zonevariable
Evidence LevelEmerging

Mechanism of Action

PBM modulates the immune response in psoriatic skin by reducing T-cell activation, decreasing pro-inflammatory cytokines (TNF-alpha, IL-17), and normalizing keratinocyte proliferation. It also promotes resolution of the vascular changes seen in psoriatic plaques.

Key Studies

  • Ablon (2010) - LED therapy for psoriasis pilot study
  • Choi et al. (2011) - Red light effects on psoriatic skin model

Treatment Tips

  • *This is adjunctive therapy, not a replacement for standard psoriasis treatment
  • *Apply directly to plaques for best results
  • *Track PASI scores to measure progress
  • *Moisturize after treatment sessions

Contraindications

  • !Photosensitive types of psoriasis
  • !Active infection in psoriatic plaques

Research Basis

This content is informed by 47+ published peer-reviewed studies on photobiomodulation.